EpiBone, Inc. Company Profile | Jersey City, NJ | Competitors ...
Find company research, competitor information, contact details & financial data for EpiBone, Inc. of Jersey City, NJ. Get the latest business insights from Dun & Bradstreet.
EpiBone, emerging biotech company, is relocating to Jersey City - ROI-NJ
2023年3月9日 · EpiBone, an emerging biotechnology company co-founded and run by Nina Marie Tandon — a biomedical engineer who holds several patents and is known for her TED Talks on engineered tissue and the future of personalized medicine — is coming to Jersey City. EpiBone, which currently is based in Brooklyn, New York, said it has outgrown its current ...
Approval of Incentives to Bring Woman-Led Company EpiBone to Jersey City
TRENTON, N.J. (March 8, 2023) –The Board of the New Jersey Economic Development Authority (NJEDA) today approved EpiBone, Inc. to receive up to $3.5 million over seven years in Emerge tax credits to secure the Brooklyn-based biotechnology company’s commitment to move to Jersey City, where it expects to create 90 full-time jobs. The project ...
Company That Grows Human Bones Gets NJ Grant To Move To Jersey City …
2023年3月20日 · EpiBone "harnesses the power of cells to create living solutions that can become a seamless part of a patient's body," said NJ's EDA. Whether due to an accident, birth defect, or aging, EpiBone...
Biotech firm takes 28,000 sq. ft. in Jersey City, plans move from ...
2023年3月9日 · A biotechnology firm is moving from Brooklyn to Jersey City after being awarded a seven-year, $3.5 million tax credit under the Economic Development Authority’s Emerge program. According to the agency, EpiBone Inc. has committed to lease 28,089 square feet at 95 Greene St., a life sciences building owned by Thor Equities Group.
After tax credit approval, EpiBone to make move from Brooklyn to Jersey …
2023年3月9日 · During its meeting March 8, the New Jersey Economic Development Authority (NJEDA) voted to approve EpiBone Inc. to receive up to $3.5 million over seven years in Emerge tax credits, setting the...
Emerge Program Leads EpiBone to Jersey City
2023年3月9日 · The New Jersey Economic Development Authority (NJEDA) yesterday approved EpiBone, Inc. to receive up to $3.5 million over seven years in Emerge tax credits to secure the Brooklyn-based biotechnology company’s commitment to move to Jersey City, where it expects to create 90 full-time jobs.
NJEDA approves $3.5M in tax credits to bring Brooklyn-based EpiBone …
2023年3月10日 · The New Jersey Economic Development Authority (NJEDA) board voted to approve $3.5 million in Emerge tax credits over seven years to bring the Brooklyn-based EpiBone to Jersey City. Photo via epibone.com. By John Heinis/Hudson County View. EpiBone grows bone and cartilage for skeletal reconstruction using stem cells to create new healthy bone ...
Innovative Biotechnology Company Set to Call Jersey City Home
2023年3月8日 · The relocation by EpiBone, Inc., a clinical stage company that grows bone and cartilage for skeletal reconstruction using stem cells to create new healthy bone, cartilage, and …
EpiBone, Inc. - CMOCRO
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft.